Candriam SCA’s Dermira, Inc. DERM Stock Holding History

Candriam SCA’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-570,000	Closed	-$8.64M	–	802
2019 Q4	$8.64M	Buy	570,000 +220,000	+63%	+$1.9M	0.09%	250
2019 Q3	$2.24M	Hold	350,000	–	–	0.03%	464
2019 Q2	$3.33M	Hold	350,000	–	–	0.04%	418
2019 Q1	$4.74M	Buy	+350,000	New	+$2.92M	0.06%	342
2018 Q2	–	Sell	-200,000	Closed	-$1.6M	–	836
2018 Q1	$1.6M	Buy	+200,000	New	+$4.35M	0.03%	521

Candriam SCA's DERM Position: Q1 2020 in Review

Candriam SCA sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 570,000 shares — an estimated $8.64M sold.

Candriam SCA first reported a position in DERM in Q1 2018 and held it in 5 quarters. The position peaked at $8.64M in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Candriam SCA reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Candriam SCA sold 570,000 Dermira, Inc. shares in Q1 2020, an estimated $8.64M.
Candriam SCA first reported a position in Dermira, Inc. in Q1 2018 and held it in 5 quarters.
Candriam SCA's Dermira, Inc. position peaked at $8.64M in Q4 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Candriam SCA's 13F filing for Q1 2020, filed 26 May 2020.